<p>Treatment of Recurrent <em>Clostridioides difficile</em> Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease</p>-Reference-Cited by-同舟云学术

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease

Published:2020-09 Issue: Volume:Volume 13 Page:563-570
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Azimirad Masoumeh,Yadegar Abbas^ORCID,Gholami Fatemeh,Shahrokh Shabnam,Asadzadeh Aghdaei Hamid^ORCID,Ianiro Gianluca,Suzuki Hidekazu^ORCID,Cammarota Giovanni,Zali Mohammad Reza

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile

2. Clostridium difficile infection in Europe: a hospital-based survey

3. Recent trends in the epidemiology and treatment of C. difficile infection in children

4. Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review;World Journal of Gastrointestinal Pharmacology and Therapeutics;2024-09-05

2. The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review;Biomedicines;2024-08-16

3. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights;Life Sciences;2024-08

4. Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury;Molecular Medicine;2024-07-19

5. Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study;Biomedicines;2024-06-23